China Isotope & Radiation Corporation (1763.HK)
1763.HK Stock Price Chart
Explore China Isotope & Radiation Corporation interactive price chart. Choose custom timeframes to analyze 1763.HK price movements and trends.
1763.HK Company Profile
Discover essential business fundamentals and corporate details for China Isotope & Radiation Corporation (1763.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
6 Jul 2018
Employees
3.37K
Website
https://www.circ.com.cnCEO
Junqi Zhang
Description
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
1763.HK Financial Timeline
Browse a chronological timeline of China Isotope & Radiation Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 19 Sept 2025
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend will be paid on 14 Nov 2025.
Dividend declared on 5 Jun 2025
A dividend of $0.34 per share was announced, adjusted to $0.34. The dividend was paid on 1 Aug 2025.
Earnings released on 28 Mar 2025
EPS came in at $0.84 , while revenue for the quarter reached $5.07B .
Dividend declared on 27 Sept 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 22 Nov 2024.
Earnings released on 30 Aug 2024
EPS came in at $0.52 , while revenue for the quarter reached $3.02B .
Dividend declared on 19 Jun 2024
A dividend of $0.34 per share was announced, adjusted to $0.34. The dividend was paid on 13 Aug 2024.
Earnings released on 27 Mar 2024
EPS came in at $0.85 , while revenue for the quarter reached $4.31B , beating expectations by +19.79%.
Earnings released on 29 Aug 2023
EPS came in at $0.43 , while revenue for the quarter reached $2.96B , missing expectations by -17.63%.
Dividend declared on 4 Jul 2023
A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 31 Aug 2023.
Earnings released on 26 Apr 2023
EPS came in at $1.00 , while revenue for the quarter reached $4.02B , beating expectations by +11.86%.
Earnings released on 31 Aug 2022
EPS came in at $0.41 , while revenue for the quarter reached $3.07B , missing expectations by -14.77%.
Dividend declared on 25 May 2022
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 22 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.88 , while revenue for the quarter reached $3.78B .
Earnings released on 31 Aug 2021
EPS came in at $0.40 , while revenue for the quarter reached $2.47B .
Dividend declared on 17 May 2021
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 26 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.53 , while revenue for the quarter reached $3.27B .
1763.HK Stock Performance
Access detailed 1763.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.